






Gangliogliomas are composed of two distinct cell populations—mature neuronal ganglion cells and neoplastic glial elements (primarily astrocytic)—with the grade of the glial component determining biological behavior
The classic partial cystic presentation with enhancing mural nodule results from increased blood-brain barrier permeability allowing plasma protein accumulation and vasogenic edema, with slow clearance leading to cyst formation
WHO grade 1 (indolent) cystic gangliogliomas have excellent prognosis with complete resection, but location determines outcome; spinal gangliogliomas often progress due to difficulty achieving adequate resection margins
BRAF V600E mutations are present in 20-60% of gangliogliomas, representing a potential molecular target; IDH is negative and if positive suggests a diffuse glioma instead
Dedifferentiation to high-grade tumors is rare (~5%) and usually involves the glial component transforming into glioblastoma, while neuronal dedifferentiation into neuroblastoma is exceptionally rare
Medically refractory temporal lobe epilepsy is the most common clinical presentation, making imaging with seizure protocol MRI essential for tumor identification and surgical planning
Clearly describe whether the lesion is cystic versus solid, document the location within the temporal lobe or other brain region, characterize enhancement pattern (minimal, variable, or prominent), note the presence of calcifications and peritumoral edema, and specifically comment on the absence of significant peritumoral FLAIR/T2 hyperintensity as a reassuring feature suggesting low-grade biology.